DH Definitive Healthcare Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: DH

Price (delayed)

$0.9073

Market cap

$95.74M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.63

Enterprise value

$107.94M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 35

Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in ...

Highlights
The debt has contracted by 6% YoY
Definitive Healthcare's quick ratio has increased by 4% from the previous quarter
DH's net income has soared by 67% YoY but it is down by 23% from the previous quarter
DH's EPS has surged by 63% year-on-year but it is down by 25% since the previous quarter
The company's equity has shrunk by 55% YoY and by 48% QoQ
The gross profit has declined by 5% year-on-year
Sector: Healthcare
Industry: Health Information Services
Website: https://www.definitivehc.com
Peers: VEEV OMCL HSTM

Key stats

What are the main financial stats of DH

DH stock price

How has the Definitive Healthcare stock price performed over time
Intraday
3.36%
1 week
2.23%
1 month
-11.91%
1 year
-74.44%
YTD
-68.39%
QTD
-26.24%

Financial performance

How have Definitive Healthcare's revenue and profit performed over time
Revenue
$238.26M
Gross profit
$181.17M
Operating income
-$240.78M
Net income
-$170.33M
Gross margin
76%
Net margin
-71.5%
Definitive Healthcare's operating income has surged by 73% YoY but it has decreased by 7% QoQ
The company's operating margin has surged by 71% YoY but it fell by 9% QoQ
DH's net income has soared by 67% YoY but it is down by 23% from the previous quarter
The net margin has soared by 65% YoY but it has contracted by 24% from the previous quarter

Price vs fundamentals

How does DH's price correlate with its fundamentals

Growth

What is Definitive Healthcare's growth rate over time

Valuation

What is Definitive Healthcare stock price valuation
P/E
N/A
P/B
0.89
P/S
0.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.45
DH's EPS has surged by 63% year-on-year but it is down by 25% since the previous quarter
The stock's price to book (P/B) is 61% less than its 5-year quarterly average of 2.2 and 46% less than its last 4 quarters average of 1.6
The company's equity has shrunk by 55% YoY and by 48% QoQ
DH's price to sales (P/S) is 93% lower than its 5-year quarterly average of 5.9 and 70% lower than its last 4 quarters average of 1.3
DH's revenue is down by 3.9% year-on-year

Efficiency

How efficient is Definitive Healthcare business performance
DH's return on sales has surged by 69% year-on-year but it is down by 19% since the previous quarter
DH's return on assets is up by 46% year-on-year but it is down by 35% since the previous quarter
The ROIC has grown by 44% YoY but it has contracted by 30% from the previous quarter
DH's ROE is down by 44% QoQ but it is up by 37% YoY

Dividends

What is DH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DH.

Financial health

How did Definitive Healthcare financials performed over time
The total assets is 59% greater than the total liabilities
The total assets has declined by 36% year-on-year and by 30% since the previous quarter
The company's total liabilities fell by 13% YoY and by 9% QoQ
The debt is 16% more than the equity
The company's debt to equity has surged by 107% YoY and by 90% QoQ
The company's equity has shrunk by 55% YoY and by 48% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.